"PURPOSE: To report the 2-year results of the MELODIE trial, which evaluated the safety and effectiveness of the balloon-expandable Express LD Vascular stent for the treatment of atherosclerotic iliac artery disease. METHODS: This prospective, multicenter, single-arm trial enrolled 151 patients (113 men; mean age 60.1?8.4 years) with 163 de novo or restenotic iliac lesions. The primary endpoint, 6-month angiographic mean percent loss of luminal diameter, was compared to an objective performance criterion (OPC) based on published results with the Palmaz stent. Follow-up included ankle-brachial index (ABI) measurement and symptom assessment (Fontaine classification) at discharge, 30 days, and 6, 12, and 24 months. Arteriography was performed at 6 months and computed tomographic angiography (CTA) at 1 and 2 years. Results: The primary endpoint of 6-month mean percent luminal diameter loss was 16.2% (upper 95% confidence boundary of 19.1%) and non-inferior to the 20% OPC (p = 0.006). Primary patency was"@en . "258510" . . . . "Dawkins, K. D." . "PURPOSE: To report the 2-year results of the MELODIE trial, which evaluated the safety and effectiveness of the balloon-expandable Express LD Vascular stent for the treatment of atherosclerotic iliac artery disease. METHODS: This prospective, multicenter, single-arm trial enrolled 151 patients (113 men; mean age 60.1?8.4 years) with 163 de novo or restenotic iliac lesions. The primary endpoint, 6-month angiographic mean percent loss of luminal diameter, was compared to an objective performance criterion (OPC) based on published results with the Palmaz stent. Follow-up included ankle-brachial index (ABI) measurement and symptom assessment (Fontaine classification) at discharge, 30 days, and 6, 12, and 24 months. Arteriography was performed at 6 months and computed tomographic angiography (CTA) at 1 and 2 years. Results: The primary endpoint of 6-month mean percent luminal diameter loss was 16.2% (upper 95% confidence boundary of 19.1%) and non-inferior to the 20% OPC (p = 0.006). Primary patency was" . "Poncyljusz, W." . . "Krzanowski, M." . "Oliva, V." . "17" . "radiology"@en . . "Peregrin, Jan" . "Express LD vascular stent in the treatment of iliac artery lesions: 24-month" . "12"^^ . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "N" . . "RIV/00023001:_____/10:00002409!RIV11-MZ0-00023001" . . "Journal of Endovascular Therapy" . "1"^^ . "Chochola, M." . "Express LD vascular stent in the treatment of iliac artery lesions: 24-month"@en . "Allocco, D. J." . "Schro\u00EB, H." . "RIV/00023001:_____/10:00002409" . "1526-6028" . . "Express LD vascular stent in the treatment of iliac artery lesions: 24-month"@en . . "Van Elst, F." . "Stockx, L." . "[303AACDE39F2]" . . "Jargiello, T." . "000283004600014" . . "Falkowski, A." . "Express LD vascular stent in the treatment of iliac artery lesions: 24-month" . "5" . "9"^^ .